08.10.26 -- How AI Is Reshaping Life Sciences M&A Deals

Join the August 20, 2026 Life Science Leader Live event at 11 AM Eastern by registering for free today. Life Science Leader Chief Editor Ben Comer and experienced panelists will discuss key changes at the FDA, how companies can get the most out of agency interactions, and strategies to lower risks and avoid regulatory surprises. Reserve your spot today.

What is the missing link between AI tools and successful pharma manufacturing? An organizational commitment to governance, orchestration, and integration across functions and data silos.

Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

Combining Functional Design of Experiments (Functional DOE) with traditional DOE methods enhances biopharmaceutical process optimization by capturing dynamic, time-based variations in cell culture systems.

Digital transformation begins with a clear framework. Explore a Maturity Model 3.0 that helps biomanufacturers assess and advance digital capabilities, enabling smarter decisions and long-term innovation.

Access to skilled talent, established R&D infrastructure, and sustained public investment has made this organization a leading destination for life sciences organizations.

See how integrated containment, advanced chromatography, and proven linker-payload optimization help streamline ADC development and support commercial readiness.

DSP failures kill commercialization timelines. Learn how integrated harvest, filtration, and purification infrastructure protects product stability at scale.